In the published article, there was an error in Figure 2 as published. In Figure 2E, the EDU experimental result images for the B-CPAP cell line NC inhibitor treatment group were misplaced. The corrected Figure 2 and its caption appear below.
Figure 2
In the published article, there was an error in Figure 4 as published. In Figure 4N, image arrangement errors occurred for the K1 cell line miR-29b-3p Mimic treatment group and the B-CPAP cell line NC Mimic, miR-29b-3p Mimic, and miR-29b-3p Mimic + OE COL5A1 treatment groups. The corrected Figure 4 and its caption appear below.
Figure 4
In the published article, there was an error in Figure 5 as published. In Figure 5L, the immunofluorescence experimental result images for the B-CPAP cell line si-COL1A1–2 treatment group were misplaced during assembly. The corrected Figure 5 and its caption appear below.
Figure 5
The original version of this article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
microRNAs, miR-29b-3p, papillary thyroid carcinoma, downregulation, COL1A1, COL5A1, gene expression
Citation
Wang C, Wang Y, Fu Z, Huang W, Yu Z, Wang J, Zheng K, Zhang S, Li S and Chen J (2025) Correction: MiR-29b-3p inhibits migration and invasion of papillary thyroid carcinoma by down-regulating COL1A1 and COL5A1. Front. Oncol. 15:1657780. doi: 10.3389/fonc.2025.1657780
Received
01 July 2025
Accepted
19 September 2025
Published
03 October 2025
Volume
15 - 2025
Edited and reviewed by
Carlos Pérez-Plasencia, National Autonomous University of Mexico, Mexico
Updates
Copyright
© 2025 Wang, Wang, Fu, Huang, Yu, Wang, Zheng, Zhang, Li and Chen.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Junqiang Chen, chenjunqiang@gxmu.edu.cn
†These authors have contributed equally to this work and share first authorship
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.